It was the turn of investment group Riverfort Global Opportunities (RGO) to step in the limelight and remind the market how conditions on the stock market have been perfectly suited to its...
Read More
On a day when stock market winners of any kind were few and far between, it was inventory monetisation specialist, Supply@Me Capital (SYME) which was one of the highest climbers. Read...
Read More
Greatland Gold (GGP) became the toast of traders after strong share price performance this week. Driving the stock higher was speculation of a 3% buy order in the market, with the...
Read More
It appeared that it was rather better to travel than arrive in terms of the latest announcement from biotech group Tiziana Life Sciences (TILS). Read More...
Read More
It would appear that every week we witness a serious multibagger re-rate in a previously unloved minnow. Indeed, some of the biggest risers this year have been and continue to...
Read More
What may or may not make the grade in the weekend press. Read More...
Read More
Former stock market favourite, Ascent Resources (AST) seemed ready for rehabilitation with its shares closing up 15% after the announcement of a new 3% stakeholder’s TR1 hit the newswires yesterday. Read More...
Read More
Alba Mineral Resources (ALBA) finished the week on a high note, with a 35% rise to close at 0.19p, with some traders anticipating that the company was due to receive planning...
Read More
Observers of United Oil & Gas (UOG) will have noted that it has been the best part of a month since its acquired production of Rockhopper’s Egyptian asset portfolio, and...
Read More
Shares of Pathfinder Minerals (PFP) were up 25% as director share buying gave the impression that a denouement as far as the long-awaited mineral sands project in Mozambique could finally...
Read More
Blockchain technology solutions group Catenae Innovation (CTEA) became the event of the day as the company’s CEO Guy Meyer appeared on Sky Business News. Read More...
Read More
4d Pharma (DDDD) proved once again that 2020 has been the blow the lights out year for pharma companies of all persuasions, not just those on the Covid-19 bandwagon. Read More...
Read More
Stocks that may or may not make tomorrow’s papers, but should. Read More...
Read More
Stocks that may or may not make tomorrow’s papers, but should. Read More...
Read More
What may or may not make the grade in the weekend press. Read More...
Read More
Stocks that (mostly) will not make the grade as far as the papers are concerned Read More...
Read More
Stocks that may or may not make the grade in the papers Read More...
Read More
What may or may not be in the papers Read More...
Read More
Drug delivery technology group Midatech Pharma (MTPH) had traders scratching their heads on Friday over the reasons for a rise of as much as 50%, as the US listing of...
Read More